Synthetic hormones and the future of contraception
The landscape of contraception for women has seen minimal change over the past 50 years, with successive generations often relying…
Women's Health
-
-
Daiichi and AstraZeneca’s Enhertu gains EC approval for breast cancers
The European Commission (EC) has approved Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) for use as a single agent to…
-
Genmab’s Tivdak approved in Japan for advanced cervical cancer
Genmab has received approval from the Japan's Ministry of Health, Labour and Welfare for Tivdak (tisotumab vedotin) to treat advanced…
-
FDA approves GSK’s Blujepa for uncomplicated UTIs
The US Food and Drug Administration (FDA) has approved GSK’s triazaacenaphthylene antibiotic, Blujepa (gepotidacin), for treating uncomplicated urinary tract infections…
-
Sermonix and Regor to enhance breast cancer treatment options
Sermonix Pharmaceuticals and Regor Therapeutics have announced a strategic partnership to discover and develop therapeutics in the breast oncology area.…
-
EC approves GSK’s Jemperli-chemo combo for endometrial cancer
The European Commission (EC) has approved GSK's Jemperli (dostarlimab) combined with chemotherapy that includes carboplatin and paclitaxel for the first-line…
-
IMPACT ovarian cancer capsules authorised in China
IMPACT Therapeutics has received the China National Medical Products Administration (NMPA) marketing authorisation for Senaparib capsules to treat ovarian cancer.…
-
EC approves Novartis’ Kisqali to treat early breast cancer
The European Commission (EC) has granted approval to Novartis' Kisqali (ribociclib), plus an aromatase inhibitor to treat early breast cancer…
-
Verastem Oncology submits NDA for ovarian cancer treatment
Verastem Oncology has concluded the rolling submission of a new drug application (NDA) to the US Food and Drug Administration…
-
FDA approves Iterum’s ORLYNVAH NDA for uUTI treatment
The US Food and Drug Administration (FDA) has approved Iterum Therapeutics' new drug application (NDA) for ORLYNVAH (sulopenem etzadroxil and…
